GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS
展开▼
机译:生长激素激素受体激动剂治疗肌萎缩侧索硬化症
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invent addresses the problem of providing a medicine for treating amyotrophic lateral sclerosis, a disease for which there is currently no effective therapeutic agent, and provides a therapeutic agent for amyotrophic lateral sclerosis that contains a growth hormone secretagogue receptor (GHS-R) agonist or a pharmaceutically acceptable salt thereof. The therapeutic agent for amyotrophic lateral sclerosis contains a GHS-R agonist such as ghrelin and is for administration to an individual who is suffering from amyotrophic lateral sclerosis and who does not exhibit severe dysphagia. The individual may be an individual who is unresponsive or insufficiently responsive to existing therapeutic agents for ALS.
展开▼